Comparative Efficacy of Baricitinib and Tofacitinib in Extensive Alopecia Areata - NI

Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Consecutive patients of Alopecia areata between ages 12 years ( >40kgs weight) -50 years, with disease duration of less than 10 years and history of current episode of at least 6 months with no evidence of spontaneous regrowth, and with severity scoring [as measured by Severity of Alopecia Tool (SALT)] of >20, shall be included (including alopecia totalis and alopecia universalis).

•1.Those with a history of intake of systemic or intralesional steroids or any other immunosuppressant drug in the preceding 2 months or of a JAK inhibitor within past 3 months
•2.History of active tuberculosis in last 3 years, significant co-morbid conditions, pregnant and lactating women shall be excluded.
•3.Co-existence of other forms of alopecia

发起方

Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Hospital